Loss of chondroitin 6- O -sulfotransferase-1 function results in severe human chondrodysplasia with progressive spinal involvement
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
We studied two large consanguineous families from Oman with a distinct form of spondyloepiphyseal dysplasia (SED Omani type). By using a genome-wide linkage approach, we were able to map the underlying gene to a 4.5-centimorgan interval on chromosome 10q23. We sequenced candidate genes from the region and identified a missense mutation in the chondroitin 6- O -sulfotransferase (C6ST-1) gene ( CHST3 ) changing an arginine into a glutamine (R304Q) in the well conserved 3′-phosphoadenosine 5′-phosphosulfate binding site. C6ST-1 catalyzes the modifying step of chondroitin sulfate (CS) synthesis by transferring sulfate to the C-6 position of the N -acetylgalactosamine of chondroitin. From the crystal structures of other sulfotransferases, it could be inferred that Arg-304 is essential for the structure of the cosubstrate binding site. We used recombinant C6ST-1 to show that the identified missense mutation completely abolishes C6ST-1 activity. Disaccharide composition analysis of CS chains by anion-exchange HPLC shows that both ΔHexA-GalNAc(6S) and ΔHexA(2S)-GalNAc(6S) were significantly reduced in the patient's cells and that ΔHexA-GalNAc(4S,6S), undetectable in controls, was elevated. Analysis of the patient's urine shows marked undersulfation of CS, in particular reduction in 6- O -sulfated disaccharide and an increase in the nonsulfated unit. Our results indicate that the mutation in CHST3 described here causes a specific but generalized defect of CS chain sulfation resulting in chondrodysplasia with major involvement of the spine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, complete deficiency of PAPSS2 causes spondyloepimetaphyseal dysplasia of the Pakistani type, but steroid metabolism was not assessed in this kindred, and women could not be studied at all (610).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [610]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed · Cited by 2,877
Easy calculations of lod scores and genetic risks on small computers.
Lathrop, M. G., & Lalouel, J.-M. (1984) · Europe PMC (PubMed Central) · Cited by 1,526
Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate
Sugahara, K., Mikami, T., Uyama, T., Mizuguchi, S., Nomura, K., & Kitagawa, H. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.09.011 · Cited by 694
Self-citationRecent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans
Sugahara, K., & Kitagawa, H. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00125-1 · Cited by 423
Self-citationSulfotransferases in glycosaminoglycan biosynthesis
Kusche-Gullberg, M. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.08.002 · Cited by 307
Akama, T. O., Nishida, K., Nakayama, J., Watanabe, H., Ozaki, K., Nakamura, T., Dota, A., Kawasaki, S., Inoue, Y., Maeda, N., et al. (2000) · Nature Genetics · doi:10.1038/79987 · Cited by 297
Kawashima, H., Atarashi, K., Hirose, M., Hirose, J., Yamada, S., Sugahara, K., & Miyasaka, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200396200 · Cited by 241
Self-citationMutations in orthologous genes in human spondyloepimetaphyseal dysplasia and the brachymorphic mouse
Haque, M. F. U., King, L. M., Krakow, D., Cantor, R. M., Rusiniak, M. E., Swank, R. T., Superti-Furga, A., Haque, S., Abbas, H., Ahmad, W., et al. (1998) · Nature Genetics · doi:10.1038/2458 · Cited by 217
Kinoshita, A., & Sugahara, K. (1999) · Analytical Biochemistry · doi:10.1006/abio.1999.4027 · Cited by 213
Self-citationRossi, A., & Superti-Furga, A. (2001) · Human Mutation · doi:10.1002/humu.1 · Cited by 195
Research works printed but not linked: 3
- Lathrop, G. M. & Lalouel, J. M. (1984) Am. J. Hum. Genet. 36, 460-465.6585139
- Kruglyak, L., Daly, M. J., Reeve-Daly, M. P. & Lander, E. S. (1996) Am. J. Hum. Genet. 58, 1347-1363.8651312
- So, C. L., Kaluarachchi, K., Tam, P. P. & Cheah, K. S. (2001) Osteoarthritis Cartilage 9, Suppl. A, S160-S173.11680681
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Taylor, K. R., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.05-4682rev · Cited by 639
“A recent familial study on patients with no chondroitin 6-O-sulfotransferase-1 function describes a form of spondyloepiphyseal dysplasia with major spinal involvement (35).”
BackgroundBiosynthesis and function of chondroitin sulfate
Mikami, T., & Kitagawa, H. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.006 · Cited by 502
Self-citationThe Regulation of Steroid Action by Sulfation and Desulfation
Mueller, J. W., Gilligan, L. C., Idkowiak, J., Arlt, W., & Foster, P. A. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1036 · Cited by 419
The Molecular Diversity of Glycosaminoglycans Shapes Animal Development
Bülow, H. E., & Hobert, O. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010605.093433 · Cited by 344
Sulfation of Glycosaminoglycans and Its Implications in Human Health and Disorders
Soares da Costa, D., Reis, R. L., & Pashkuleva, I. (2017) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071516-044610 · Cited by 324
Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Yamada, S., & Sugahara, K. (2008) · Current Drug Discovery Technologies · doi:10.2174/157016308786733564 · Cited by 241
“[51] studied a distinct form of spondyloepiphyseal dysplasia (SED Omani type).”
BackgroundSelf-citationCongenital disorders of glycosylation
Chang, I. J., He, M., & Lam, C. T. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.45 · Cited by 235
Klüppel, M., Wight, T. N., Chan, C., Hinek, A., & Wrana, J. L. (2005) · Development · doi:10.1242/dev.01948 · Cited by 198
“During development and in disease, chondroitin sulfation on carbon positions 4 (C4S) and 6 (C6S) is tightly controlled both spatially and temporally (Kitagawa et al., 1997; Theocharis et al., 2003; Tsara et al., 2002).”
BackgroundWopereis, S., Lefeber, D. J., Morava, E., & Wevers, R. A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.063040 · Cited by 191
“Mutations can be found in the corresponding gene (111).”
BackgroundInfluentialGlycosaminoglycans from marine sources as therapeutic agents
Valcarcel, J., Novoa-Carballal, R., Pérez-Martín, R. I., Reis, R. L., & Vázquez, J. A. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.07.008 · Cited by 188
Inactivating PAPSS2 Mutations in a Patient with Premature Pubarche
Noordam, C., Dhir, V., McNelis, J. C., Schlereth, F., Hanley, N. A., Krone, N., Smeitink, J. A., Smeets, R., Sweep, F. C. G. J., Grinten, H. L. C.-V. D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810489 · Cited by 169
Chan, D., Song, Y., Sham, P., & Cheung, K. M. C. (2006) · European Spine Journal · doi:10.1007/s00586-006-0171-3 · Cited by 160
“An example is a recent report for mutations in the chondroitin 6-O-sulphotransferase-1 (C6ST-1) gene (CHST3) giving rise to severe spinal involvement [62].”
BackgroundLoss of Dermatan-4-Sulfotransferase 1 Function Results in Adducted Thumb-Clubfoot Syndrome
Dündar, M., Müller, T., Zhang, Q., Pan, J., Steinmann, B. U., Vodopiutz, J., Gruber, R. W., Sonoda, T., Krabichler, B., Utermann, G., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.11.010 · Cited by 150
The Different Roles of Aggrecan Interaction Domains
Aspberg, A. (2012) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155412464376 · Cited by 130
“…tail and limbs Kurima et al. 1998; ul Haque et al. 1998 Brachyolmia, recessive (PAPS synthase 2 — Short trunk dysplasia Miyake et al. 2012 SED Omani type (C6ST-1) — SED Thiele et al. 2004 Chondrodysplasia, GPAPP type (IMPAD1) — Chondrodysplasia with joint dislocations Vissers et al. 2011 Impaired…”
BackgroundLumbar disc degeneration is linked to a carbohydrate sulfotransferase 3 variant
Song, Y., Karasugi, T., Cheung, K., Chiba, K., Ho, D. W., Miyake, A., Kao, P. Y. P., Sze, K., Yee, A., Takahashi, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69277 · Cited by 127
Self-citationDiseases of glycosylation beyond classical congenital disorders of glycosylation
Hennet, T. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.02.001 · Cited by 127
Contactin-1 is a functional receptor for neuroregulatory chondroitin sulfate-E
Mikami, T., Yasunaga, D., & Kitagawa, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809227200 · Cited by 124
Self-citationFaulty Initiation of Proteoglycan Synthesis Causes Cardiac and Joint Defects
Baasanjav, S., Al‐Gazali, L., Hashiguchi, T., Mizumoto, S., Fischer‐Zirnsak, B., Horn, D., Seelow, D., Ali, B. R., Aziz, S., Langer, R. D., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.021 · Cited by 143
Self-citationRac1 Signaling Stimulates N-cadherin Expression, Mesenchymal Condensation, and Chondrogenesis
Woods, A., Wang, G., Dupuis, H., Shao, Z., & Beier, F. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700680200 · Cited by 122
Notochord Cells in Intervertebral Disc Development and Degeneration
McCann, M. R., & Séguin, C. A. (2016) · Journal of Developmental Biology · doi:10.3390/jdb4010003 · Cited by 140
Congenital disorders of glycosylation: a concise chart of glycocalyx dysfunction
Hennet, T., & Cabalzar, J. (2015) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.03.002 · Cited by 117
Hiraoka, S., Furuichi, T., Nishimura, G., Shibata, S., Yanagishita, M., Rimoin, D. L., Superti‐Furga, A., Nikkels, P. G. J., Ogawa‐Tominaga, M., Katsuyama, K., et al. (2007) · Nature Medicine · doi:10.1038/nm1655 · Cited by 117
“5% polyoxyethylene(10) lauryl ether, and then removed the urea by dialysis.”
BackgroundGlycosaminoglycan affinity of the complete fibroblast growth factor family
Asada, M., Shinomiya, M., Suzuki, M., Honda, E., Sugimoto, R., Ikekita, M., & Imamura, T. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.09.001 · Cited by 126
Pudełko, A., Wisowski, G., Olczyk, K., & Koźma, E. M. (2019) · FEBS Journal · doi:10.1111/febs.14748 · Cited by 121
Glycosylation diseases: Quo vadis?
Schachter, H., & Freeze, H. H. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.11.002 · Cited by 111
Freidin, M. B., Tsepilov, Y. A., Palmer, M. R., Karssen, L. C., CHARGE Musculoskeletal Working Group, Suri, P., Aulchenko, Y. S., & Williams, F. M. K. (2019) · Pain · doi:10.1097/j.pain.0000000000001514 · Cited by 119
Mizumoto, S., Ikegawa, S., & Sugahara, K. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.437038 · Cited by 106
Self-citationHermanns, P., Unger, S., Rossi, A., Aytés, A. P., Cortina, H., Bonafé, L., Boccone, L., Setzu, V., Dutoit, M., Sangiorgi, L., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.006 · Cited by 111
Vissers, L. E. L. M., Lausch, E. U., Unger, S., Campos‐Xavier, B., Gilissen, C., Rossi, A., del Rosario, M., Venselaar, H., Knoll, U., Nampoothiri, S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.002 · Cited by 111
Nadanaka, S., Ishida, M., Ikegami, M., & Kitagawa, H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802997200 · Cited by 93
Self-citationRatzka, A., Kalus, I., Moser, M., Dierks, T., Mundlos, S., & Vortkamp, A. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21423 · Cited by 90
Self-citationConsanguinity and Dysmorphology in Arabs
Al‐Gazali, L., & Hamamy, H. (2014) · Human Heredity · doi:10.1159/000360421 · Cited by 90
Mizumoto, S., Fongmoon, D., & Sugahara, K. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9463-5 · Cited by 89
“For example, CS structures containing C-, D-, and E-units play roles in bone development, neuritogenesis, inflammation/leukocyte trafficking, viral infections, and tumor metastasis [5–10].”
BackgroundSelf-citationPerlecan, the “jack of all trades” proteoglycan of cartilaginous weight‐bearing connective tissues
Melrose, J., Hayes, A. J., Whitelock, J. M., & Little, C. B. (2008) · BioEssays · doi:10.1002/bies.20748 · Cited by 82
Syed, F. A., Mödder, U. I., Fraser, D. G., Spelsberg, T. C., Rosen, C. J., Krust, A., Chambon, P., Jameson, J. L., & Khosla, S. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050713 · Cited by 81
Unger, S., Lausch, E., Rossi, A., Mégarbané, A., Sillence, D., Alcausin, M., Aytes, A., Mendoza‐Londono, R., Nampoothiri, S., Afroze, B., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33641 · Cited by 81
“In all cases studies so far, the biochemical data suggest a severe impairment or abolishment of the sulfotransferase activity [Thiele et al., 2004; Hermanns et al., 2008; van Roij et al., 2008; Tuysuz et al., 2009; and the present paper].”
BackgroundIzumikawa, T., Sato, B., & Kitagawa, H. (2014) · Scientific Reports · doi:10.1038/srep03701 · Cited by 78
Self-citationCartault, F., Munier, P., Jacquemont, M.-L., Vellayoudom, J., Doray, B., Payet, C., Randrianaivo, H., Laville, J.-M., Munnich, A., & Cormier-Daire, V. (2015) · European Journal of Human Genetics · doi:10.1038/ejhg.2014.60 · Cited by 75
Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathy
Çırak, S., von Deimling, F., Sachdev, S., Errington, W. J., Herrmann, R., Bönnemann, C. G., Brockmann, K., Hinderlich, S., Lindner, T. H., Steinbrecher, A., et al. (2010) · Brain · doi:10.1093/brain/awq108 · Cited by 79
“PCRs of fluorescent labelled microsatellite markers were performed as described elsewhere (Thiele et al., 2004).”
MethodSelf-citationDawson, P. A. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.03.004 · Cited by 82
Paganini, C., Costantini, R., Superti‐Furga, A., & Rossi, A. (2019) · FEBS Journal · doi:10.1111/febs.14984 · Cited by 77
A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation
Frederick, J. P., Tafari, A. T., Wu, S.-M., Megosh, L. C., Chiou, S.-T., Irving, R. P., & York, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801182105 · Cited by 67
Glycosaminoglycans are functional ligands for receptor for advanced glycation end‐products in tumors
Mizumoto, S., & Sugahara, K. (2013) · FEBS Journal · doi:10.1111/febs.12156 · Cited by 72
Self-citationDubail, J., Huber, C., Chantepie, S., Sonntag, S., Tüysüz, B., Mıhçı, E., Gordon, C. T., Steichen‐Gersdorf, E., Amiel, J., Nur, B. G., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05191-8 · Cited by 67
Nizon, M., Huber, C., Leonardis, F. D., Merrina, R., Forlino, A., Fradin, M., Tüysüz, B., Abu‐Libdeh, B., Alanay, Y., Albrecht, B., et al. (2012) · Human Mutation · doi:10.1002/humu.22104 · Cited by 63
“Furthermore, many clinical features are common to spondyloepiphyseal dysplasia, Omani type, or humerospinal dysostosis other well-described entities caused by defects in CHST3 [Hermanns et al., 2008; Thiele et al, 2004; Van Roij et al., 2008].”
BackgroundBiosynthesis of glycosaminoglycans: associated disorders and biochemical tests
Sasarman, F., Maftei, C., Campeau, P. M., Brunel‐Guitton, C., Mitchell, G. A., & Allard, P. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9903-z · Cited by 71
Koike, T., Izumikawa, T., Tamura, J., & Kitagawa, H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.024 · Cited by 57
Self-citationTat, S. K., Pelletier, J., Mineau, F., Duval, N., & Martel‐Pelletier, J. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.090696 · Cited by 56
Tüysüz, B., Mizumoto, S., Sugahara, K., Çelebi, A., Mundlos, S., & Turkmen, S. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01167.x · Cited by 55
“The DNA fragment, which encodes the human C6ST-1-wild type (WT) protein lacking the first N-terminal 48 amino acids including the predicted transmembrane region, was amplified by PCR with the pGEM-T Easy vector containing the full-length form of C6ST-1 (pGEM-T EasyC6ST-1) as a template and using a 5#-primer containing…”
BackgroundMethodSelf-citationHuman genetic disorders and knockout mice deficient in glycosaminoglycan
Mizumoto, S., Yamada, S., & Sugahara, K. (2014) · BioMed Research International · doi:10.1155/2014/495764 · Cited by 54
“Arg304Gln, have severe kyphoscoliosis, a short stature, mild brachydactyly, rhizomelia, fusion of the carpal bones, and osteoarthritis in the elbow, wrist, and knee joints [108, 109].”
BackgroundSelf-citationGenetics and pathophysiology of mammalian sulfate biology
Langford, R., Hurrion, E. M., & Dawson, P. A. (2016) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2016.08.001 · Cited by 59
Spondyloepiphyseal dysplasia, Omani type: Further definition of the phenotype
van Roij, M. H. H., Mizumoto, S., Yamada, S., Morgan, T., Tan-Sindhunata, G. M. B., Meijers-Heijboer, H. E. J., Verbeke, J. I. M. L., Markie, D., Sugahara, K., & Robertson, S. P. (2008) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32482 · Cited by 61
“All affected individuals were homozygous for a 911G!A transition resulting in an arginine to glutamine substation (R304Q) within exon 3 of CHST3, the gene that encodes the enzyme chondroitin 6-O-sulfotransferase-1 (C6ST-1) [Thiele et al., 2004].”
BackgroundSelf-citationThyroid Hormone Regulates Heparan Sulfate Proteoglycan Expression in the Growth Plate
Bassett, J. H. D., Swinhoe, R., Chassande, O., Samarut, J., & Williams, G. R. (2006) · Endocrinology · doi:10.1210/en.2005-0485 · Cited by 53
Guo, M. H., Stoler, J., Lui, J., Nilsson, O., Bianchi, D. W., Hirschhorn, J. N., & Dauber, A. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36128 · Cited by 52
“For example, mutations in carbohydrate sulfotransferase 3 (CHST3) are known to cause spondyloepiphyseal dysplasia with congenital joint dislocations [Thiele et al., 2004], with features that include dysplasia and subluxation of the elbow and short stature.”
BackgroundCongenital Disorders of Deficiency in Glycosaminoglycan Biosynthesis
Mizumoto, S., & Yamada, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.717535 · Cited by 61
“Homozygous mutations in CHST3 cause spondyloepiphyseal dysplasia with congenital joint dislocations, which is characterized by a short stature, severe kyphoscoliosis, mild brachydactyly, arthritic joints, joint dislocation, rhizomelia, fusion of the carpal bones, metacarpal shortening, osteoarthritis of the elbow, dea…”
BackgroundBiosynthesis of Glycosaminoglycans and Proteoglycans
Uyama, T., Kitagawa, H., & Sugahara, K. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00036-2 · Cited by 62
Self-citationBartolomé, N., Segarra, S., Artieda, M., Francino, O., Sánchez-Robert, E., Szczypiorska, M., Casellas, J., Tejedor, D., Cerdeira, J., Martínez, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122558 · Cited by 71
“Mutations in the CHST3 gene have been previously found as associated with spondyloepiphyseal dysplasia in humans, which is a congenital skeletal development disorder characterized by joint dislocations, included hip dislocation [36,37].”
BackgroundProteoglycans and Glycosaminoglycans in Stem Cell Homeostasis and Bone Tissue Regeneration
Chen, J., Sun, T., You, Y., Wu, B., Wang, X., & Wu, J. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760532 · Cited by 61
Osipovich, A. B., Jennings, J. L., Lin, Q., Link, A. J., & Ruley, H. E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804259105 · Cited by 49
Wiweger, M. I. K. N., Avramut, M. C., Andrea, C. E. D., Prins, F. A., Koster, A. J., Ravelli, R. B. G., & Hogendoorn, P. C. W. (2010) · The Journal of Pathology · doi:10.1002/path.2824 · Cited by 44
Placental, Renal, and Ileal Sulfate Transporter Gene Expression in Mouse Gestation1
Dawson, P. A., Rakoczy, J., & Simmons, D. G. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.111.098749 · Cited by 40
Woods, A., Khan, S. M., & Beier, F. (2007) · Endocrinology · doi:10.1210/en.2007-0695 · Cited by 44
Src kinase inhibition promotes the chondrocyte phenotype
Bursell, L., Woods, A., James, C. G., Pala, D., Leask, A., & Beier, F. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2308 · Cited by 41
“In cartilage, chondroitin 6 sulphotransferase (encoded by Chst3) and chondroitin 4 sulphotransferase (Chst11) are of particular importance, as documented by the consequences of mutations in these genes in humans or mice [11,12].”
BackgroundDawson, P. A., Elliott, A., & Bowling, F. G. (2015) · Nutrients · doi:10.3390/nu7031594 · Cited by 43
“Skeletal phenotypes are also found in patients with mutations in the chondroitin 6-O-sulphotransferase gene (step 5 in Figure 2B) [80], showing that chondroitin sulphonation is important for maintaining healthy skeletal development.”
BackgroundAkatsu, C., Mizumoto, S., Kaneiwa, T., Maccarana, M., Malmström, A., Yamada, S., & Sugahara, K. (2010) · Glycobiology · doi:10.1093/glycob/cwq208 · Cited by 38
“Defective 6-O-sulfation of CS causes chondrodysplasia and skeletal dysplasia (Thiele et al. 2004; van Roij et al. 2008; Tuysuz et al. 2009).”
BackgroundSelf-citationSkeletal Dysplasias Caused by Sulfation Defects
Paganini, C., Tota, C. G., Superti‐Furga, A., & Rossi, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082710 · Cited by 44
Ritelli, M., Chiarelli, N., Zoppi, N., Dordoni, C., Quinzani, S., Traversa, M., Venturini, M., Calzavara-Pinton, P., & Colombi, M. (2015) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2014.11.005 · Cited by 37
Chondroitin sulfate-E mediates estrogen-induced osteoanabolism
Koike, T., Mikami, T., Shida, M., Habuchi, O., & Kitagawa, H. (2015) · Scientific Reports · doi:10.1038/srep08994 · Cited by 36
Self-citationMendoza‐Londono, R., Chitayat, D., Kahr, W. H. A., Hinek, A., Blaser, S., Dupuis, L., Goh, E., Badilla‐Porras, R., Howard, A., Mittaz, L., et al. (2012) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35339 · Cited by 37
Role of sulphate in development
Dawson, P. A. (2013) · Reproduction · doi:10.1530/rep-13-0056 · Cited by 38
Recognition of Sulfation Pattern of Chondroitin Sulfate by Uronosyl 2-O-Sulfotransferase
Ohtake, S., Kimata, K., & Habuchi, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508816200 · Cited by 34
Kitagawa, H., Tsutsumi, K., Ikegami‐Kuzuhara, A., Nadanaka, S., Goto, F., Ogawa, T., & Sugahara, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803279200 · Cited by 42
Self-citationHan, J., Li, D., Qu, C., Wang, D., Wang, L., Guo, X., & Lammi, M. J. (2017) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2017.02.803 · Cited by 31
Prinz, R. D., Willis, C., Kuppevelt, T. H. V., & Klüppel, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092381 · Cited by 32
“Moreover, missense mutations in the human Carbohydrate sulfotransferase 3 (CHST3) gene, involved in the production of CS, have been shown to be associated with Larsen syndrome, humero-spinal dysostosis [24], and Omani-type spondyloepiphyseal dysplasia [25], all of which cause severe”
BackgroundMizumoto, S., Watanabe, M., Yamada, S., & Sugahara, K. (2013) · BioMed Research International · doi:10.1155/2013/656319 · Cited by 37
“Rights(URL) https://creativecommons.org/licenses/by/3.0/ Type article File Information BMRI2013 656319.pdf Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP”
InfluentialSelf-citationChondroitin sulfate and growth factor signaling in the skeleton: Possible links to MPS VI
Alliston, T. N. (2010) · Journal of Pediatric Rehabilitation Medicine · doi:10.3233/prm-2010-0117 · Cited by 34
“In addition, mutations in the chondroitin 6-O-sulfotransferase-1 gene are associated with human chondrodysplasia [66].”
BackgroundCommon Autosomal Recessive Diseases in Oman Derived from a Hospital-Based Registry
Rajab, A., Bappal, B., Al-Shaikh, H., Al-Khusaibi, S., & Mohammed, A. J. (2005) · Public Health Genomics · doi:10.1159/000083334 · Cited by 30
Self-citationCongenital disorders of glycosylation and intellectual disability
Wolfe, L. A., & Krasnewich, D. M. (2013) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.1115 · Cited by 31
“These patients do not have any intellectual disabilities [Thiel et al., 2004].”
BackgroundInfluentialMonti, L., Paganini, C., Lecci, S., Leonardis, F. D., Haÿ, E., Cohen-Solal, M. E., Villani, S., Superti‐Furga, A., Tenni, R., Forlino, A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv289 · Cited by 32
“In addition, GAG sulfation was altered in the urine of a patient with spondyloepiphyseal dysplasia, Omani type, a recessive chondrodysplasia with a defect in GAG sulfation (38).”
BackgroundHellicar, J., Stevenson, N. L., Stephens, D. J., & Lowe, M. (2022) · Journal of Cell Science · doi:10.1242/jcs.258879 · Cited by 32
“Hermanns et al., 2008; Thiele et al., 2004 Carbohydrate sulfotransferase 6 (CHST6) Sulfotransferase.”
BackgroundElimination of breast tumor-associated chondroitin sulfate promotes metastasis
Prinz, R. D., Willis, C., Viloria‐Petit, A., & Klüppel, M. (2011) · Genetics and Molecular Research · doi:10.4238/2011.december.8.9 · Cited by 30
“Strikingly increased levels of chondroitin sulfates and CSPGs have been observed in the microenvironment of a number of human solid tumors, including melanoma, ovarian adenocarcinomas, hepatocarcinoma, prostate tumors, colon adenocarcinoma, and breast cancer (Olsen et al., 1988; Kovalszky et al., 1990; Alini and Losa,…”
BackgroundInfluentialUsing Sugar Remodeling to Study Chondroitin Sulfate Function
Kitagawa, H. (2014) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00613 · Cited by 34
Self-citationSaigoh, K., Izumikawa, T., Koike, T., Shimizu, J., Kitagawa, H., & Kusunoki, S. (2010) · Journal of Human Genetics · doi:10.1038/jhg.2010.148 · Cited by 28
Self-citationKawamura, D., Funakoshi, T., Mizumoto, S., Sugahara, K., & Iwasaki, N. (2014) · Journal of Orthopaedic Science · doi:10.1007/s00776-014-0643-y · Cited by 33
“Moreover, mutations in the genes of sulfotransferases, active sulfate synthetase or nucleotide-sugar transporters, which are indispensable for the synthesis of CS, cause chondrodysplasia in mice and humans [9–14].”
BackgroundSelf-citationShabbir, R. M. K., Nalbant, G., Ahmad, N., Malik, S., & Tolun, A. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2017-105003 · Cited by 28
Matrix Disruptions, Growth, and Degradation of Cartilage with Impaired Sulfation
Mertz, E. L., Facchini, M., Pham, A. T., Gualeni, B., Leonardis, F. D., Rossi, A., & Forlino, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116467 · Cited by 30
Following the enzymatic digestion of chondroitin sulfate by a simple GPC analysis
Silva, C., Novoa-Carballal, R., Reis, R. L., & Pashkuleva, I. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.05.034 · Cited by 25
Mizumoto, S., Murakoshi, S., Kalayanamitra, K., Deepa, S. S., Fukui, S., Kongtawelert, P., Yamada, S., & Sugahara, K. (2012) · Glycobiology · doi:10.1093/glycob/cws137 · Cited by 27
“Recent studies have revealed that C-, D- and E-units in CS chains are involved in bone formation (Thiele et al. 2004; van Roij et al. 2008; Tuysuz et al. 2009), neuritogenesis (Clement et al.”
BackgroundSelf-citationYusa, A., Kitajima, K., & Habuchi, O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600140200 · Cited by 27
Spondyloepimetaphyseal dysplasia Pakistani type: Expansion of the phenotype
Tüysüz, B., Yılmaz, S., Gül, E., Kolb, L., Bilguvar, K., Evliyaoğlu, O., & Günel, M. (2013) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.35906 · Cited by 25
Genomic approaches to diagnose rare bone disorders
Falardeau, F., Camurri, M. V., & Campeau, P. M. (2016) · Bone · doi:10.1016/j.bone.2016.07.020 · Cited by 27
López‐Senra, E., Casal-Beiroa, P., López‐Álvarez, M., Serra, J., González, P., Valcárcel, J., Vázquez, J. A., Burguera, E. F., Blanco, F. J., & Magalhães, J. (2020) · Marine Drugs · doi:10.3390/md18020094 · Cited by 25
“In addition, mutations in STs genes cause cartilage and bone abnormalities, which highlight the importance of CS sulfation in chondrogenic differentiation [11].”
BackgroundRoles of Chondroitin Sulfate Proteoglycans as Regulators of Skeletal Development
Schwartz, N. B., & Domowicz, M. S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.745372 · Cited by 30
Waryah, A. M., Shahzad, M., Shaikh, H., Sheikh, S. A., Channa, N. A., Hufnagel, R. B., Makhdoom, A., Riazuddin, S. A., & Ahmed, Z. M. (2015) · Clinical Genetics · doi:10.1111/cge.12694 · Cited by 23
“Previously, mutations in CHST3 have been associated with a rare phenotype of skeleton dysplasia, known as spondyloepiphyseal dysplasia with congenital joint dislocations (OMIM 143095) (9, 10).”
BackgroundChondrodysplasia with multiple dislocations: comprehensive study of a series of 30 cases
Ranza, E., Huber, C., Levin, N. A., Baujat, G., Bôle‐Feysot, C., Nitschké, P., Masson, C., Alanay, Y., Al‐Gazali, L., Bitoun, P., et al. (2016) · Clinical Genetics · doi:10.1111/cge.12885 · Cited by 28
“The others are recessive disorders, including Desbuquois dysplasia type 1 and Kim variant (MIM 251450, DBQD1), linked to CANT1 variants (MIM 613165) (5), Desbuquois dysplasia type 2 (MIM 615777, DBQD2), due to XYLT1 variants (MIM 608124) (6), Spondylo-epiphyseal dysplasia with dislocations (MIM 143095), associated wit…”
BackgroundChondroitin / Dermatan Sulfate Modification Enzymes in Zebrafish Development
Habicher, J., Haitina, T., Eriksson, I., Holmborn, K., Dierker, T., Ahlberg, P., & Ledin, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0121957 · Cited by 23
“5 in the neuroepithelium of the forebrain region, and is particularly strong in the dorsal aspects of the neural folds [22].”
BackgroundLeveraging osteoclast genetic regulatory data to identify genes with a role in osteoarthritis
Mullin, B. H., Zhu, K., Brown, S. J., Mullin, S., Dudbridge, F., Pavlos, N. J., Richards, J. B., Grundberg, E., Bell, J. T., Zeggini, E., et al. (2023) · Genetics · doi:10.1093/genetics/iyad150 · Cited by 20
“Mutation in this gene has been found to cause spondyloepiphyseal dysplasia, a rare disorder with a variety of severe skeletal traits including joint dislocations and arthritic changes (Thiele et al. 2004).”
BackgroundHao, D., Xiao, P., & Chen, S. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-4062-9 · Cited by 21
Schneeberger, P. E., von Elsner, L., Barker, E. L., Meinecke, P., Marquardt, I., Alawi, M., Steindl, K., Joset, P., Rauch, A. M., Zwijnenburg, P. J. G., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.10.007 · Cited by 23
“1058 The American Journal of Human Genetics 107, 1044–1061, Dec transferase 3 or chondroitin 6-O-sulfotransferase 1 lead to functional impairment of the enzyme.(64,65) EDSMC1 is caused by bi-allelic pathogenic variants in CHST14 that encodes the carbohydrate sulfotransferase 14 (also named dermatan 4-O-sulfotransferas…”
Background
Metadata
- Authors
- Thiele, H., Sakano, M., Kitagawa, H., Sugahara, K., Rajab, A., Höhne, W., Ritter, H., Leschik, G., Nürnberg, P., & Mundlos, S.
- Affiliations
- Institute of Medical Genetics and Institute of Biochemistry, Charité University Hospital, Humboldt University, Berlin 13353, Germany; Gene Mapping Center, Max Delbrück Center for Molecular Medicine, Berlin 13092, Germany; Department of Biochemistry, Kobe Pharmaceutical University, Higashinada, Kobe 658-8558, Japan; Genetic Unit, Directorate General of Health Affairs, Ministry of Health, 138 Muscat, Sultanate of Oman; and Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany
- Kobe Pharmaceutical University (JP)
- Corresponding author
- Mundlos, Stefan
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-06-23
- Volume
- 101
- Issue
- 27
- Pages
- 10155-10160
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC454181
- OpenAlex
- W2133789497
- Cited by
- 190
- References
- 28
- Citations by year
- 2026: 9 · 2025: 5 · 2024: 6 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 15 · 2014: 14 · 2013: 12 · 2012: 15
- FWCI
- 2.29
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- CHST3, chondrodysplasia, consanguineous family, chromosome 10q23, spinal involvement
- MeSH terms
- Carbohydrate Sulfotransferases, Binding Sites, Fibroblasts, Humans, Models, Biological, Osteochondrodysplasias, Spinal Diseases, Sulfotransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.